(Q54697940)

3 June 2018

title

MK2 signaling: lessons on tissue specificity in modulation of inflammation. (English)

1 reference

3 June 2018

0 references

1

1 reference

3 June 2018

author name string

Sampsa Matikainen

series ordinal

2

1 reference

3 June 2018

Antti Lauerma

series ordinal

3

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 February 2010

1 reference

3 June 2018

Journal of Investigative Dermatology

published in

1 reference

3 June 2018

volume

130

1 reference

3 June 2018

issue

2

1 reference

3 June 2018

page(s)

342-344

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1038/jid.2009.372

exact match

0 references

cites work

Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

Potential adverse effects associated with inhibition of p38alpha/beta MAP kinases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

Targeting innate immunity protein kinase signalling in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

NLRs join TLRs as innate sensors of pathogens

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activity.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

The discovery of carboline analogs as potent MAPKAP-K2 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.372

7 January 2021

Identifiers

DOI

10.1038/JID.2009.372

1 reference

3 June 2018

PubMed ID

20081887

1 reference

3 June 2018